Last update :
31/05/2020
References   References 4391  
Type : Poster
Icone.pdf
1161Ko

Research teams : Toronto - Sunnybreak Health Sciences Center
Authors : Charbonneau L.F, Iazetta J, Ma N.H, Law S, Walker S.E.
Title : Stability of a New Generic Formulation of Bortezomib Injection (MDA brand) In Vials and Syringes Stored at 4°C and Room Temperature (25°C).
Reference : Sunnybrook Health Sciences Centre 2020

Level of Evidence : 
Level of evidence B
Physical stability : 
Chemical stability : 
Other methods : 
Comments : 

List of drugs
InjectionBortezomib Anticancer drug
Stability in solutions Glass Sodium chloride 0,9% 1,0 mg/ml 25°C Not specified
62 Day
Stability in solutions Glass Sodium chloride 0,9% 1,0 mg/ml 4°C Not specified
84 Day
Stability in solutions Glass Sodium chloride 0,9% 2,5 mg/ml 25°C Not specified
62 Day
Stability in solutions Glass Sodium chloride 0,9% 2,5 mg/ml 4°C Not specified
84 Day
Stability in solutions Polypropylen Syringe Sodium chloride 0,9% 1,0 mg/ml 25°C Not specified
62 Day
Stability in solutions Polypropylen Syringe Sodium chloride 0,9% 1,0 mg/ml 4°C Not specified
84 Day
Stability in solutions Polypropylen Syringe Sodium chloride 0,9% 2,5 mg/ml 25°C Not specified
62 Day
Stability in solutions Polypropylen Syringe Sodium chloride 0,9% 2,5 mg/ml 4°C Not specified
84 Day

  Mentions Légales